Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2023-02-04 History
Report ID 173235
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 10mL LifeShield syringes
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-14
Estimated end date
Actual end date 2023-02-03
Shortage status Resolved
Updated date 2023-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-01 English Compare
v2 2022-11-01 French Compare
v3 2022-12-14 English Compare
v4 2022-12-14 French Compare
v5 2022-12-15 English Compare
v6 2023-01-31 English Compare
v7 2023-01-31 French Compare
v8 2023-02-03 English Compare
v9 2023-02-03 French Compare
v10 2023-02-04 English Compare

Showing 1 to 10 of 10